|
|
University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Ctr. advancing health worldwide ™ | |
UCSF INSTITUTE FOR HEALTH & AGING ◊ UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
 |
| David Smith |
Email: drSmith@hafci.org
Telephone: (415) 487-3688
David E. Smith, M.D., Ph.D., is a Visiting Research Physician, who served as State Medical Specialist for a substance abuse services grant at the Institute for Health & Aging at the University of California, San Francisco.
In 1967, Dr. Smith founded the Haight Ashbury Free Clinics in San Francisco where he continues to serve as Medical Director. He is a fellow and past President of the American Society of Addiction Medicine. He is also Medical Director at the California State Department of Alcohol and Drug Programs, and is Associate Clinical professor, Clinical Toxicology and Occupational Health, at the School of Medicine, University of California, San Francisco.
Since 1984, Dr. Smith has served as Research Director at MPI Treatment Services at Summit Medical Center in Oakland, California. In addition, Dr. Smith served as Visiting Associate Clinical Professor of Behavioral Pharmacology, Department of Psychiatry, University of Nevada Medical School, Reno, Nevada.
Title: State Medical Director on Substance Abuse
Project Period: 10/1/05-6/30/06
Funding Agencyies: Department of Alcohol and Drug Programs (ADP),
State of California
Description: Dr. Smith serves as the State Medical Director on
Substance Abuse Services, providing clinical consultation and direction
regarding public health quality assurance, training on an effective
provision of substance treatment, as well as other aspects of the
alcohol and other drug continuum of care, primary medical care, and
infection control.
Title: Substance Abuse Prevention and Treatment (SAPT)
Project Period: 7/1/98-6/30/05
Funding Agencies: Department of Health Alcohol and Drug Program,
State of California (ADP)
Description: Dr. Smith and his staff work in consultation with the
ADP Department Executive Staff to provide review and consultation to
assist in (1) the development and review of a post-service/post-payment
utilization review of Short-Doyle Drug/Medi-Cal services, (2) the
development of a managed system of care for substance abuse services,
(3) collaboration with the Dept. of Health Services, the review of
protocols, standards, and regulations designed to effectively control
the spread of infectious disease, and (3) addressing other state health
policies and issues.
Title: Alcohol and Drug Program (ADP) Substance Abuse Program Treatment
Project Period: 7/1/00-6/30/03
Funding Agencies: Department of Health Alcohol and Drug Program,
State of California
Description: To provide clinical consultation and direction regarding
effective substance abuse treatment, primary medical care and infection
control, and public health quality assurance.
Title: Technical Assistance to Department of Health, Alcohol and Drug Program (ADP)
Project Period: 7/1/98-6/30/00
Funding Agencies: Department of Health, Alcohol and Drug Program, State of California
Description: Dr. Smith provided AOD prevention technical assistance to counties and
local AOD prevention programs, as well as ADP. These services
included helping counties and providers (1) understand how to use PAD
and data that can be locally acquired to identify, assess, and
prioritize local AOD prevention needs on a sustained basis; (2) select
and deliver practical, proven and relevant prevention actions; and (3)
Measure outcomes and the use of results to refine and improve AOD
prevention.
Ling, W, Wesson, DR, Smith, DE. Prescription Opiate Abuse. Substance Abuse: A Comprehensive Textbook, Lowinson, JH, Ruiz, P, Millman, RB, Langrod, JG, eds. pp. 459-468, Lippincott, Williams & Wilkins, 2005.
Smith, DE, Glatt, W, Tucker, DE, Deutsch, R, Seymour, R. Drug Testing in the Workplace: Integrating Medical Review Officer Duties into Occupational Medicine. Occupational Medicine: State of the Art Reviews, Volume 17(1), pp. 79-90, January-March 2002.
Ling, W & Smith, DE. Buprenorphine: blending practice and research. Journal of Substance Abuse Treatment, Volume 23(2002), pp. 87-92.
Smith DE & Wesson DR. Benzodiazepine and Other Sedative-Hypnotic Dependence. Textbook of Substance Abuse Treatment, Second Edition. Galanter, M & Kleber, HD, eds., American Psychiatric Press, pp. 239 - 250, 1999.
Smith, DE & Seymour, RB. Overcoming Cultural Points of Resistance to Spirituality in the Practice of Addiction Medicine. Addiction and Spirituality: A multidsciplinary Approach. Morgan, OJ, & Jornan, M., eds., pp. 95 - 109, Chalice Press, 1999.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(1), January-February, 1999, p.7.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(2), March-April, 1999, p. 7.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(3), May-June 1999, p. 7.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(4), July-August, 1999, p. 7.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(5), September-October, 1999, p.7.
Smith, D & Heilig, S. “Medicalizing” American Drug Policy -- A Much-Needed Focus on Prevention & Treatment. San Francisco Medicine, Volume 72 (10), pp. 28 - 30, November/December, 1999.
Seymour, RB & Smith, DE. Psychological and Psychiatric Consequences of Hallucinogens. Handbook of Substance Abuse: Neurobehavioral Pharmacology. RE Tarter, RT Ammerman & PJ Ott, eds., pp. 241 - 251, Plenum Press, 1998.
Wesson, D, Smith, DE, Ling, W. Pharmacologic Therapies for Benzodiazepine and other sedative-hypnotic addiction. Principles of Addiction Medicine, second ed. 517-530, 1998.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(1), January-February, 1998.
Smith, DE & Seymour, RB. International Addictions Infoline. Journal of Psychoactive Drugs. Volume 30 (1), pp. 111-117, January-March, 1998.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(2), March-April, 1998.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(3), May-June, 1998.
Smith, DE. Review of the AMA Council on Scientific Affairs Report on Medical Marijuana. Journal of Psychoactive Drugs. Volume 30(2), pp. 127-136, April-June, 1998.
Calhoun, SR, Galloway, G & Smith, DE. Abuse Potential of Dronabinol (Marinol®). Journal of Psychoactive Drugs. Volume 30(2), pp. 187-196, April-June, 1998.
Smith, DE, Ehrlich, P & Seymour, R. Current Trends in Adolescent Drug Use. San Francisco Medicine. Volume 71(5), pp. 22-23, 26, June, 1998.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(4), July-August-June, 1998.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(5), September-October, 1998.
Smith DE & Heilig, S, Editors. Marijuana at The Millenium: Medical and Social Implications. Journal of Psychoactive Drugs, Volume 30(2), 1998.
Smith DE, Galloway GP, Frederick SL, Staggers FE, Gonzalez M, Stalcup SA. 1997. Gammahydroxybutyrate: An Emerging Drug of Abuse that Causes Physicial Dependence. Addiction. Volume 92(1), pp. 89-96.
Smith DE & Seymour, RB. Benzodiazepine: Disintossicazione. Medicine delle Tossicodipendenze (Italian Journal of the Addictions). Vol. 5, 1-2, 1997.
Smith DE & Miller NS. The Integration of Pharmacotherapy and Nonpharmacotherapy. Journal of Addiction Diseases. Volume 16, pp. 51-64, Number 4, 1997.
Smith DE & Seymour RB. Addiction Medicine and the Free Clinic Movement. Journal of Psychoactive Drugs. Volume 29, pp. 155-160, April-June, 1997.
Smith DE & Seymour RB. The Many Meaning of Free. Humanism in the Health Sciences. Volume 2, pp. 6-7, Fall, 1997.
Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 4(6), November-December, 1997.
Seymour, RB, Smith DE. Treatment of Protracted Drug-Induced Syndromes. In Norman S. Miller, MD, ed. The Principles and Practice of Addictions in Psychiatry. W.B. Saunders Company, Philadelphia, 1997.
Dupont, RL, Smith, DE, Deutsch, R, Clark, HW, Editors. Drugs, Crime & Violence. Journal of Psychoactive Drugs, Volume 29(4), 1997.
Smith, DE & Seymour, RB. Cannabis and Cannabis Withdrawal. Journal of Substance Misuse, 2(1), 1997.
Smith, DE, Galloway, GP & Seymour, RB. Methamphetamine Abuse and Treatment. Valparaiso University Law Review, 1997.
Seymour, RB & Smith, DE. Benzodiazepine Use and Misuse. Medicina delle Tossicodipendenze (The Italian Drug Abuse Journal), 1997.
Smith DE, Galloway GP, Newmeyer J, Knapp T, Stalcup SA. A Controlled Trial of Imipramine for the Treatment of Methamphetamine Dependence. Journal of Substance Abuse Treatment, Vol. 13, pp. 493-497, November, 1996.
Smith DE, Miller NS & Gold MS. Manual of Therapeutics for Addictions. John Wiley & Sons, Inc.,1997.
Smith DE, Galloway GP, Seymour RB. Methamphetamine: An Old Problem Returns. American Society of Addiction Medicine News. 11(1): 6-7, 1996.
Smith DE, Frederick SL, Galloway GP, Staggers FE, Stalcup SA. Gammahydroxybutyrate: A Putative Neurotransmitter That is Abused and Causes Physical Dependence. in Harris, LS (ed): Problems of Drug Dependence, 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. Rockville, MD. National Institute on Drug Abuse, 1996.
Smith DE. The 1995 Distinguished Lecturer in Substance Abuse. Journal of Substance Abuse Treatment. Vol. 13(4), pp. 289-294, 1996.
Smith, DE & Seymour, RB. Advances in Anticaving Agents: Adjunctive Use of Medication Continues as Relapse Prevention Strategy. Employee Assistance, 8(4), 1996
Smith, DE, Lawlor B, & Seymour, RB. Health Care at the Crossroads. San Francisco Medicine, 69(6), 1996.
Smith DE, Calhoun SR, Galloway GP, Wesson DR. 1996. Abuse of Flunitrezepam (Rohypnol) and other Benzodiazepines in Austin and Southeast Texas. Journal of Psychoactive Drugs, 28(2).
Smith DE & Wesson DR. Benzodiazepine and Other Sedative-Hypnotic Dependence. Treatment of Psychiatric Disorders, Second Edition, American Psychiatric Press, Volume 1, pp. 673-683, 1995.
Smith DE, Wesson DR & Calhoun SR. Rohypnol: Quaalude of the Nineties? CSAM News, Summer 1995, Volume 22, No. 2.
Wesson DR & Smith DE. Benzodiazepines and Other Sedative-Hypnotics. Textbook of Substance Abuse Treatment. The American Psychiatric Press, pp. 179-190, 1994.
Smith DE. AA Recovery and Spirituality: An Addiction Medicine Perspective; Response Paper. Journal of Substance Abuse Treatment, Volume 11(2), pp. 111-112, 1994.
Wesson DR, Ling W, Smith DE. Zolpidem: An Addiction Medicine Perspective. California Society of Addiction Medicine News, Spring, 1994.
Wesson DR, Smith DE & Ling W. Prescription Drug Abuse and Addiction. Hazelden Educational Materials, Center City, MN, 1994.
Smith DE & Seymour RB. LSD: History and Toxicity. Psychiatric Annals, Volume 24(3), pp. 145-147, March, 1994.
Seymour RB, Smith DE & Ehrlich P. Counseling the Adolescent Drug Abuse Client. Plenum Publishing Corporation, New York, 1993.
Seymour RB & Smith DE. Crack Cocaine: Prevention, Intervention & Spirituality. Treatment Centers Magazine, 1993.
Wesson DR, Smith DE & Seymour RB. Sedative Hypnotics and Tricyclics. Synopsis of Substance Abuse. Williams and Wilkins, Baltimore, 1993.
Wesson DR, Smith DE & Seymour RB. Sedative-Hypnotics and Tricyclics. Clinical Handbook of Substance Abuse. Williams and Wilkins, Baltimore, 1993.
Smith DE, Buxton ME, Bilal R & Seymour RB. Cultural Points of Resistance to the Twelve Step Recovery Process. Journal of Psychoactive Drugs, 1993.
Wesson DR, Ling W & Smith DE. Prescription of Opioids for Treatment of Pain in Patients with Addictive Disease. Journal of Pain and Symptom Management, Volume 8(5), pp. 289-296, July, 1993.
Smith DE, Wesson DR & Ling W. Treatment of Multiple Drug/Alcohol Intoxication and Withdrawal. ASAM Principles of Addiction, ASAM, 1993.
Wesson DR, Smith DE & Washburn P. Medical Aspects of Chemical Dependency. Hazelden, 1993.
Seymour RB & Smith DE. The Psychedelic Resurgence. Hazelden, 1993.
Morrison MA, Smith DE, Wilford B, Ehrlich, P & Seymour RB. At War in the Fields of Play: Current Perspectives on the Nature and Treatment of Adolescent Chemical Dependency. Journal of Psychoactive Drugs, Volume 25(4), October-December, 1993.
Smith DE. Haight Ashbury Revisited. Proceedings of the Hallucinogens, LSD and Raves Symposium, National Press Club, November, 1993.
Smith DE & Seymour RB. Drugs in the Workplace. Occupational Health and Safety, National Safety Council, Itasca, Illinois, 1992.
Landry MJ, Smith DE, McDuff DR & Baughman OL. Benzodiazepine Dependence and Withdrawal: Identification and Medical Management. Journal of Family Practice, Volume 5(2), 1992.
Smith DE, Lusher T & Seymour RB. Benzodiazepines and Other Sedative-Hypnotic Detoxification. Manual of the Detoxification of the Pregnant Addict. Department of Health Services, State of California, 1992.
Smith DE & Seymour RB. Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling, Continuum Publishing Group, New York, 1991.
Smith DE & Seymour RB. Benzodiazepines. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel Dekker, Inc., New York, 1991.
Seymour RB & Smith DE. Hallucinogens. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel Dekker, Inc., New York, 1991.
Smith DE, Ehrlich P & Seymour RB. Current Trends in Adolescent Drug Use. Psychiatric Annals, Volume 21(2), 1991.
Landry MJ, Smith DE, McDuff D, et al. Anxiety and Substance Abuse Disorders: A Primer for Primary Care Physicians. American Journal of Family Practice, Volume 4(1), pp. 447-456, July, 1991.
Landry M, Smith DE, McDuff D, et al. Anxiety and Substance Abuse Disorders: The Treatment of High Risk Patients. American Journal of Family Practice, Volume 4(1), pp. 447-456, July, 1991.
Smith DE & Seymour RB. Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling. Continuum Publishing Group, New York, 1991.
Zweben JE, Smith DE & Stewart P. Psychotic Conditions and Substance Abuse Use: Prescribing Guidelines and Other Treatment Issues. Journal of Psychoactive Drugs, Volume 23(4), 1991.
Landry MJ, Smith DE & Steinberg JR. Anxiety, Depression and Substance Abuse Disorders: Diagnosis, Treatment and Prescribing Practices. Journal of Psychoactive Drugs, Volume 23(4), 1991.
Wesson DR, Smith DE & Seymour RB. Sedative-Hypnotics and Tricyclics. Substance Abuse: A Comprehensive Textbook. Williams and Wilkins, Baltimore, Maryland, 1991.
Smith DE. Addiction Medicine and Primary Care. Western Journal of Medicine, May, 1990.
Smith DE & Wesson DR. Prescription Drug Abuse: Patient, Physician and Cultural Responsibilities. Western Journal of Medicine, Volume 152, pp. 613-616, May 1990.
Landry MJ & Smith DE. Benzodiazepine Dependency Discontinuation: Focus on the Chemical Dependency Detoxification Setting and Benzodiazepine Polydrug Abuse. Journal of Psychoactive Drugs, Volume 24(2), pp. 145-156, 1990.
Seymour RB & Smith DE. Identifying and Responding to Drug Abuse in the Workplace: An Overview. Journal of Psychoactive Drugs, Volume 22(4), 1990.
Smith DE. The Addictive Disease: Controversy and Understanding. Conference Address, 1989.
Smith DE & Seymour RB. The Evolution of Drug Use: The Changing Street Drug Scene. California Pharmacist, August, 1989.
Smith DE. From the 60's to the 90's: The Evolution of Chemical Dependency Treatment. The Counselor, September-October, 1989.
Smith DE. Hazards of Cocaine Becoming Notorious. U.S. Journal of Alcohol and Chemical Dependence, Volume 13(5), May, 1989.
Smith DE & Zweben, JE. Considerations in Using Psychotropic Medicine with Dual Diagnosis Patients in Recovery. Journal of Psychoactive Drugs, Volume 21(2), pp. 221-228, April-June, 1989.
Smith DE & Heilig S. Addiction Medicine Alert. San Francisco Medicine, Volume 19, November, 1989.
Smith DE, Wesson DR, Camber S & Landry MJ. Perceptions of Benzodiazepine and Cocaine Abuse by US Addiction Specialists. National Directorate for Prevention of Alcohol and Drug Problems, Volume 4, pp. 371-390, 1989.
Smith DE, Wesson DR & Landry MJ. The Pharmacology of Benzodiazepine Addiction. Selective Therapeutic Index, Volume 2(9), pp. 94-107, September, 1989.
Smith DE & Landry MJ. AIDS and Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume 20(2), April-June, 1988.
Smith DE. Should the U.S. Legalize Narcotics? U.S. Journal of Alcohol and Chemical Dependence, Volume 12(8), August, 1988.
Smith DE & Heilig S. Addiction Update 1988: Treatable Diseases. San Francisco Medicine, Volume 32(2), August, 1988.
Landry MJ & Smith DE. AIDS and Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume 20(2), pp. 141-147, 1988.
Smith DE, Wesson DR, Sees KL & Morgan JP. An Epidemiological and Clinical Analysis of Propylhexedrine Abuse in the United States. Journal of Psychoactive Drugs, Volume 20(4), pp. 441-442, 1988.
Smith DE & Wesson DR. Substance Abuse in Industry: Identification, Intervention, Treatment and Prevention, 1988.
Smith DE & Landry MJ. Psychoactive Substance Use Disorders: Drugs and Alcohol. General Psychiatry, Second Edition, pp. 266-285, 1988.
Smith DE & Seymour RB. Clinical Issues on Drugs and the Law. Perspectives on Drug Abuse - Volume 1, Freund Publishing House, Tel Aviv, 1988.
Smith DE, Wesson DR, Steffens S & Jue K. L-Tryptophan Treatment of Cocaine Dependency and the Eodinophilia Myalgia Syndrome. Problems of Drug Dependence, NIDA Research Monograph #132, Rockville, Maryland, 1992.
Smith DE & Wesson DR. Cocaine: Treatment Perspectives. Cocaine Use in America: Epidemiological and Clinical Perspectives, Institute on Drug Abuse Research Monograph Series 61, 1985.
Schermann, JM, Sandouk, P, Redureau, M, Galons, H, Hiance, M, Kaplan, SA, Smith, DE. Inhibition of cocaine brain uptake and facilitation of cocaine efflux from the brain by a systemic specific antibody. Published abstract. College on Problems of Drug Dependence (CPDD), 61st Annual Scientific Meeting, June 12 - 17, 1999, Acapulco, Mexico.
Kaplan, SA, Smith, DE, Markland, P, Perkins, BH, Ferrell, TM, Fulton, R, Nettles, HS, Staas, JK, Tice, TR. In vivo confirmation of naltrexone sustained release by microencapsulation in poly(D,L-lactide) for prolonged drug addiction therapy. Published abstract. College on Problems of Drug Dependence (CPDD), 61st Annual Scientific Meeting, June 12 - 17, 1999, Acapulco, Mexico.
Smith, DE & Seymour, RB. Clinician's Guide to Substance Abuse. McGraw-Hill Medical Publishing Division, 2001.
Wesson DR, Smith DE, Steffens SC, Co-Editors. Crack and Ice: Treating Smokable Stimulant Abuse. Hazelden Foundation, Center City, 1992.
Wesson DR & Smith DE. Treating Opiate Dependency. Hazelden Foundation, Minneapolis, 1989.
Seymour RB, Smith DE, Inaba DE & Landry MJ. The New Drugs: Look Alike Drugs, Drugs of Deception and Designer Drugs. Hazelden Foundation, Center City, 1989.
Smith DE & Wesson DR. Treating Cocaine Dependency. Hazelden Foundation, Minneapolis, 1988.
Seymour RB & Smith DE. The Physician's Guide to Psychoactive Drugs. The Haworth Press, New York, 1987.
Seymour RB & Smith DE. Guide to Psychoactive Drugs: An Up to the Minute Reference to Mind Altering Substances. Harrington Park Press, New York, 1987.
Seymour RB & Smith DE. Drugfree: A Unique, Positive Approach to Staying off Alcohol and Other Drugs. Facts on File Publications, New York, 1987.
Seymour RB & Smith DE. Still Free After All These Years: Two Decades With The Haight Ashbury Free Medical Clinic. Westwind Associates, Sausalito, 1987.
Smith DE, Gold MS, Olden K & Dwyer BJ. Cocaine: Helping Patients Avoid the End of the Line. 1985.
Smith DE & Wesson DR. Treating the Cocaine Abuser. Hazelden Foundation, 1985.
Smith DE, Co-Editor. The Benzodiazepines: Current Standards for Medical Practice. MTP Press, Ltd., Boston, 1985.
Haight Ashbury Heroin Film, 1999.
Haight Ashbury Video Series, Cinemed, Inc., 1988.
The Haight Ashbury Cocaine Film, Cinemed, Inc., 1985.
Uppers, Downers, All Arounders, Cinemed Inc., 1984.
Through the Looking Glass, Hazelden, 1984.
Film on the National Commission on Marijuana and Drug Abuse Report, 1973.
UCSF INSTITUTE FOR HEALTH & AGING ◊ SCHOOL OF NURSING
◊ University of California, San Francisco
3333 California St., #LHts-340, San Francisco, CA 94143-0646
More information, contact: mariechristine.yue@ucsf.edu
This page is: http://sbs.ucsf.edu/iha/faculty/smith.htm
Last revised: July, 2007; Apr. 2008
© Copyright 2008 University of California Regents, All Rights Reserved.
